tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CHRS is currently covered by 11 analysts with an average price target of $11.87. This is a potential upside of $9.72 (452.09%) from yesterday's end of day stock price of $2.15.
Coherus BioSciences's activity chart (see below) currently has 66 price targets and 77 ratings on display. The stock rating distribution of CHRS is 80.65% BUY and 19.35% HOLD.
Analysts average stock forecasts to be materialized ratio is 6.73% with an average time for these price targets to be met of 75.23 days.
Highest price target for CHRS is $14, Lowest price target is $7, average price target is $11.87.
Most recent stock forecast was given by ROBYN KARNAUSKAS from TRUIST on 23-Jan-2024. First documented stock forecast 27-Jul-2016.
Currently out of the existing stock ratings of CHRS, 25 are a BUY (80.65%), 6 are a HOLD (19.35%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
7
$4.49 (178.88%)
12
2 months 25 days ago
0/4 (0%)
$4.6 (191.67%)
Buy
13
$10.49 (417.93%)
3 months 21 days ago
0/13 (0%)
$10.31 (383.27%)
Hold
22
5 months 9 days ago
3/8 (37.5%)
$7.72 (54.06%)
181
Buy
20
5 months 10 days ago
0/3 (0%)
$14.89 (291.39%)
Buy
14
$11.49 (457.77%)
13
5 months 18 days ago
0/2 (0%)
$10.99 (365.12%)
What is CHRS (Coherus BioSciences) average time for price targets to be met?
Which analyst has the current highest performing score on CHRS (Coherus BioSciences) with a proven track record?
Which analyst has the most public recommendations on CHRS (Coherus BioSciences)?
Which analyst is the currently most bullish on CHRS (Coherus BioSciences)?
Which analyst is the currently most reserved on CHRS (Coherus BioSciences)?
